Advantage Alpha Capital Partners LP Has $2.05 Million Stock Holdings in Axon Enterprise, Inc. (NASDAQ:AXON)

Advantage Alpha Capital Partners LP lowered its stake in shares of Axon Enterprise, Inc. (NASDAQ:AXON) by 38.8% in the third quarter, HoldingsChannel reports. The institutional investor owned 5,139 shares of the biotechnology company’s stock after selling 3,255 shares during the period. Advantage Alpha Capital Partners LP’s holdings in Axon Enterprise were worth $2,054,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also modified their holdings of the company. Blue Trust Inc. boosted its position in Axon Enterprise by 987.5% during the second quarter. Blue Trust Inc. now owns 87 shares of the biotechnology company’s stock valued at $27,000 after purchasing an additional 79 shares during the last quarter. Quent Capital LLC lifted its holdings in shares of Axon Enterprise by 1,875.0% during the 3rd quarter. Quent Capital LLC now owns 79 shares of the biotechnology company’s stock valued at $32,000 after buying an additional 75 shares during the last quarter. Asset Dedication LLC bought a new stake in shares of Axon Enterprise in the 2nd quarter valued at approximately $47,000. Planning Capital Management Corp increased its holdings in Axon Enterprise by 83.3% in the third quarter. Planning Capital Management Corp now owns 121 shares of the biotechnology company’s stock worth $48,000 after buying an additional 55 shares during the last quarter. Finally, Friedenthal Financial bought a new position in Axon Enterprise during the third quarter valued at approximately $51,000. 79.08% of the stock is currently owned by hedge funds and other institutional investors.

Insider Activity at Axon Enterprise

In related news, Director Julie A. Cullivan sold 900 shares of Axon Enterprise stock in a transaction dated Thursday, September 5th. The stock was sold at an average price of $353.53, for a total transaction of $318,177.00. Following the sale, the director now directly owns 3,653 shares of the company’s stock, valued at $1,291,445.09. This trade represents a 19.77 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, President Joshua Isner sold 20,000 shares of the company’s stock in a transaction that occurred on Tuesday, November 12th. The shares were sold at an average price of $606.15, for a total value of $12,123,000.00. Following the completion of the transaction, the president now directly owns 208,166 shares of the company’s stock, valued at approximately $126,179,820.90. This trade represents a 8.77 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 260,256 shares of company stock worth $105,984,120 in the last ninety days. 5.70% of the stock is currently owned by insiders.

Analyst Upgrades and Downgrades

AXON has been the subject of several recent research reports. Robert W. Baird boosted their target price on shares of Axon Enterprise from $440.00 to $460.00 and gave the stock an “outperform” rating in a research report on Monday, November 4th. Needham & Company LLC increased their target price on shares of Axon Enterprise from $525.00 to $600.00 and gave the stock a “buy” rating in a research report on Friday, November 8th. JMP Securities boosted their price target on Axon Enterprise from $430.00 to $500.00 and gave the stock a “market outperform” rating in a research report on Thursday, October 31st. The Goldman Sachs Group increased their price objective on Axon Enterprise from $385.00 to $441.00 and gave the company a “buy” rating in a report on Wednesday, October 23rd. Finally, Northland Securities boosted their target price on Axon Enterprise from $365.00 to $550.00 and gave the stock an “outperform” rating in a report on Monday, November 11th. Two analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $427.83.

Axon Enterprise Stock Down 2.8 %

Shares of AXON stock opened at $619.00 on Tuesday. The stock has a 50 day moving average of $468.24 and a 200-day moving average of $370.65. The firm has a market cap of $47.20 billion, a PE ratio of 159.95, a price-to-earnings-growth ratio of 14.02 and a beta of 0.94. The company has a quick ratio of 2.63, a current ratio of 2.96 and a debt-to-equity ratio of 0.32. Axon Enterprise, Inc. has a 12 month low of $224.28 and a 12 month high of $641.20.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.